Assessment of power spectral density of microvascular hemodynamics in skeletal muscles at very low and low-frequency via near-infrared diffuse optical spectroscopies
- PMID: 38021143
- PMCID: PMC10659778
- DOI: 10.1364/BOE.502618
Assessment of power spectral density of microvascular hemodynamics in skeletal muscles at very low and low-frequency via near-infrared diffuse optical spectroscopies
Erratum in
-
Erratum: Assessment of power spectral density of microvascular hemodynamics in skeletal muscles at very low and low-frequency via near-infrared diffuse optical spectroscopies: erratum.Biomed Opt Express. 2024 Apr 29;15(5):3425. doi: 10.1364/BOE.528504. eCollection 2024 May 1. Biomed Opt Express. 2024. PMID: 38855693 Free PMC article.
Abstract
In this work, we used a hybrid time domain near-infrared spectroscopy (TD-NIRS) and diffuse correlation spectroscopy (DCS) device to retrieve hemoglobin and blood flow oscillations of skeletal muscle microvasculature. We focused on very low (VLF) and low-frequency (LF) oscillations (i.e., frequency lower than 0.145 Hz), that are related to myogenic, neurogenic and endothelial activities. We measured power spectral density (PSD) of blood flow and hemoglobin concentration in four muscles (thenar eminence, plantar fascia, sternocleidomastoid and forearm) of 14 healthy volunteers to highlight possible differences in microvascular hemodynamic oscillations. We observed larger PSDs for blood flow compared to hemoglobin concentration, in particular in case of distal muscles (i.e., thenar eminence and plantar fascia). Finally, we compared the PSDs measured on the thenar eminence of healthy subjects with the ones measured on a septic patient in the intensive care unit: lower power in the endothelial-dependent frequency band, and larger power in the myogenic ones were observed in the septic patient, in accordance with previous works based on laser doppler flowmetry.
© 2023 Optica Publishing Group under the terms of the Optica Open Access Publishing Agreement.
Conflict of interest statement
The role in the project of all the companies and their employees involved (pioNIRS s.r.l., ASPHALION S.L, BioPixs Ltd, HemoPhotonics S.L.) has been defined by the project objectives, tasks, and work packages and has been reviewed by the European Commission (European Union's Horizon 2020 research and innovation programme, VASCOVID project, grant agreement No. 101016087). ICFO has equity ownership in the spin-off company HemoPhotonics S.L. and UMW is the CEO. TD and UMW are inventors on relevant patents. All the potential financial conflicts of interest and objectivity of research have been monitored by ICFO’s Knowledge & Technology Transfer Department. No financial conflicts of interest were identified. M.B., M.L. A.T., A.T., and D.C. are cofounders of pioNIRS S.r.l., (Italy).
Figures
References
-
- Flammer A. J., Anderson T., Celermajer D. S., Creager M. A., Deanfield J., Ganz P., Hamburg N. M., Lüscher T. F., Shechter M., Taddei S., Vita J. A., Lerman A., “The assessment of endothelial function: From research into clinical practice,” Circulation 126(6), 753–767 (2012).10.1161/CIRCULATIONAHA.112.093245 - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources